Industry Research Reports

Home > Reports > Chemical & Material > Beta-Eudesmol- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Beta-Eudesmol- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Industry: Chemical & Material

Published Date: 2025-02-21

Pages: 85 Pages

Report ld: 4155424

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

The global market for Beta-Eudesmol was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.

Beta-Eudesmol, a sesquiterpenoid alcohol isolated from Atractylodes lancea rhizoma, potentiates the neuromuscular blocking effect of succinylcholine.

North American market for Beta-Eudesmol was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Beta-Eudesmol was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Beta-Eudesmol was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The global key companies of Beta-Eudesmol include Santa Cruz Biotechnology (SCBT), Merck KGaA (Sigma-Aldrich), AdooQ, etc. In 2024, the global five largest players hold a share approximately % in terms of revenue.

This report aims to provide a comprehensive presentation of the global market for Beta-Eudesmol, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Beta-Eudesmol by region & country, by Type, and by Application.

The Beta-Eudesmol market size, estimations, and forecasts are provided in terms of sales volume (Kg) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Beta-Eudesmol.

MARKET SEGMENTATION

By Company

Santa Cruz Biotechnology (SCBT)
Merck KGaA (Sigma-Aldrich)
AdooQ

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Natural Type
Synthetic Type

Segment by Application

Essence
Sanitary Products
Industrial Products
Others

biaoTi CHAPTER OUTLINE

Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Beta-Eudesmol manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Sales, revenue of Beta-Eudesmol in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Sales, revenue of Beta-Eudesmol in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Market Overview

1.1 Beta-Eudesmol Product Introduction

1.2 Global Beta-Eudesmol Market Size Forecast

1.2.1 Global Beta-Eudesmol Sales Value (2020-2031)

1.2.2 Global Beta-Eudesmol Sales Volume (2020-2031)

1.2.3 Global Beta-Eudesmol Sales Price (2020-2031)

1.3 Beta-Eudesmol Market Trends & Drivers

1.3.1 Beta-Eudesmol Industry Trends

1.3.2 Beta-Eudesmol Market Drivers & Opportunity

1.3.3 Beta-Eudesmol Market Challenges

1.3.4 Beta-Eudesmol Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Beta-Eudesmol Players Revenue Ranking (2024)

2.2 Global Beta-Eudesmol Revenue by Company (2020-2025)

2.3 Global Beta-Eudesmol Players Sales Volume Ranking (2024)

2.4 Global Beta-Eudesmol Sales Volume by Company Players (2020-2025)

2.5 Global Beta-Eudesmol Average Price by Company (2020-2025)

2.6 Key Manufacturers Beta-Eudesmol Manufacturing Base and Headquarters

2.7 Key Manufacturers Beta-Eudesmol Product Offered

2.8 Key Manufacturers Time to Begin Mass Production of Beta-Eudesmol

2.9 Beta-Eudesmol Market Competitive Analysis

2.9.1 Beta-Eudesmol Market Concentration Rate (2020-2025)

2.9.2 Global 5 and 10 Largest Manufacturers by Beta-Eudesmol Revenue in 2024

2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Beta-Eudesmol as of 2024)

2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Natural Type

3.1.2 Synthetic Type

3.2 Global Beta-Eudesmol Sales Value by Type

3.2.1 Global Beta-Eudesmol Sales Value by Type (2020 VS 2024 VS 2031)

3.2.2 Global Beta-Eudesmol Sales Value, by Type (2020-2031)

3.2.3 Global Beta-Eudesmol Sales Value, by Type (%) (2020-2031)

3.3 Global Beta-Eudesmol Sales Volume by Type

3.3.1 Global Beta-Eudesmol Sales Volume by Type (2020 VS 2024 VS 2031)

3.3.2 Global Beta-Eudesmol Sales Volume, by Type (2020-2031)

3.3.3 Global Beta-Eudesmol Sales Volume, by Type (%) (2020-2031)

3.4 Global Beta-Eudesmol Average Price by Type (2020-2031)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Essence

4.1.2 Sanitary Products

4.1.3 Industrial Products

4.1.4 Others

4.2 Global Beta-Eudesmol Sales Value by Application

4.2.1 Global Beta-Eudesmol Sales Value by Application (2020 VS 2024 VS 2031)

4.2.2 Global Beta-Eudesmol Sales Value, by Application (2020-2031)

4.2.3 Global Beta-Eudesmol Sales Value, by Application (%) (2020-2031)

4.3 Global Beta-Eudesmol Sales Volume by Application

4.3.1 Global Beta-Eudesmol Sales Volume by Application (2020 VS 2024 VS 2031)

4.3.2 Global Beta-Eudesmol Sales Volume, by Application (2020-2031)

4.3.3 Global Beta-Eudesmol Sales Volume, by Application (%) (2020-2031)

4.4 Global Beta-Eudesmol Average Price by Application (2020-2031)

5 Segmentation by Region

5.1 Global Beta-Eudesmol Sales Value by Region

5.1.1 Global Beta-Eudesmol Sales Value by Region: 2020 VS 2024 VS 2031

5.1.2 Global Beta-Eudesmol Sales Value by Region (2020-2025)

5.1.3 Global Beta-Eudesmol Sales Value by Region (2026-2031)

5.1.4 Global Beta-Eudesmol Sales Value by Region (%), (2020-2031)

5.2 Global Beta-Eudesmol Sales Volume by Region

5.2.1 Global Beta-Eudesmol Sales Volume by Region: 2020 VS 2024 VS 2031

5.2.2 Global Beta-Eudesmol Sales Volume by Region (2020-2025)

5.2.3 Global Beta-Eudesmol Sales Volume by Region (2026-2031)

5.2.4 Global Beta-Eudesmol Sales Volume by Region (%), (2020-2031)

5.3 Global Beta-Eudesmol Average Price by Region (2020-2031)

5.4 North America

5.4.1 North America Beta-Eudesmol Sales Value, 2020-2031

5.4.2 North America Beta-Eudesmol Sales Value by Country (%), 2024 VS 2031

5.5 Europe

5.5.1 Europe Beta-Eudesmol Sales Value, 2020-2031

5.5.2 Europe Beta-Eudesmol Sales Value by Country (%), 2024 VS 2031

5.6 Asia Pacific

5.6.1 Asia Pacific Beta-Eudesmol Sales Value, 2020-2031

5.6.2 Asia Pacific Beta-Eudesmol Sales Value by Region (%), 2024 VS 2031

5.7 South America

5.7.1 South America Beta-Eudesmol Sales Value, 2020-2031

5.7.2 South America Beta-Eudesmol Sales Value by Country (%), 2024 VS 2031

5.8 Middle East & Africa

5.8.1 Middle East & Africa Beta-Eudesmol Sales Value, 2020-2031

5.8.2 Middle East & Africa Beta-Eudesmol Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Beta-Eudesmol Sales Value Growth Trends, 2020 VS 2024 VS 2031

6.2 Key Countries/Regions Beta-Eudesmol Sales Value

6.2.1 Key Countries/Regions Beta-Eudesmol Sales Value, 2020-2031

6.2.2 Key Countries/Regions Beta-Eudesmol Sales Volume, 2020-2031

6.3 United States

6.3.1 United States Beta-Eudesmol Sales Value, 2020-2031

6.3.2 United States Beta-Eudesmol Sales Value by Type (%), 2024 VS 2031

6.3.3 United States Beta-Eudesmol Sales Value by Application, 2024 VS 2031

6.4 Europe

6.4.1 Europe Beta-Eudesmol Sales Value, 2020-2031

6.4.2 Europe Beta-Eudesmol Sales Value by Type (%), 2024 VS 2031

6.4.3 Europe Beta-Eudesmol Sales Value by Application, 2024 VS 2031

6.5 China

6.5.1 China Beta-Eudesmol Sales Value, 2020-2031

6.5.2 China Beta-Eudesmol Sales Value by Type (%), 2024 VS 2031

6.5.3 China Beta-Eudesmol Sales Value by Application, 2024 VS 2031

6.6 Japan

6.6.1 Japan Beta-Eudesmol Sales Value, 2020-2031

6.6.2 Japan Beta-Eudesmol Sales Value by Type (%), 2024 VS 2031

6.6.3 Japan Beta-Eudesmol Sales Value by Application, 2024 VS 2031

6.7 South Korea

6.7.1 South Korea Beta-Eudesmol Sales Value, 2020-2031

6.7.2 South Korea Beta-Eudesmol Sales Value by Type (%), 2024 VS 2031

6.7.3 South Korea Beta-Eudesmol Sales Value by Application, 2024 VS 2031

6.8 Southeast Asia

6.8.1 Southeast Asia Beta-Eudesmol Sales Value, 2020-2031

6.8.2 Southeast Asia Beta-Eudesmol Sales Value by Type (%), 2024 VS 2031

6.8.3 Southeast Asia Beta-Eudesmol Sales Value by Application, 2024 VS 2031

6.9 India

6.9.1 India Beta-Eudesmol Sales Value, 2020-2031

6.9.2 India Beta-Eudesmol Sales Value by Type (%), 2024 VS 2031

6.9.3 India Beta-Eudesmol Sales Value by Application, 2024 VS 2031

7 Company Profiles

7.1 Santa Cruz Biotechnology (SCBT)

7.1.1 Santa Cruz Biotechnology (SCBT) Company Information

7.1.2 Santa Cruz Biotechnology (SCBT) Introduction and Business Overview

7.1.3 Santa Cruz Biotechnology (SCBT) Beta-Eudesmol Sales, Revenue, Price and Gross Margin (2020-2025)

7.1.4 Santa Cruz Biotechnology (SCBT) Beta-Eudesmol Product Offerings

7.1.5 Santa Cruz Biotechnology (SCBT) Recent Development

7.2 Merck KGaA (Sigma-Aldrich)

7.2.1 Merck KGaA (Sigma-Aldrich) Company Information

7.2.2 Merck KGaA (Sigma-Aldrich) Introduction and Business Overview

7.2.3 Merck KGaA (Sigma-Aldrich) Beta-Eudesmol Sales, Revenue, Price and Gross Margin (2020-2025)

7.2.4 Merck KGaA (Sigma-Aldrich) Beta-Eudesmol Product Offerings

7.2.5 Merck KGaA (Sigma-Aldrich) Recent Development

7.3 AdooQ

7.3.1 AdooQ Company Information

7.3.2 AdooQ Introduction and Business Overview

7.3.3 AdooQ Beta-Eudesmol Sales, Revenue, Price and Gross Margin (2020-2025)

7.3.4 AdooQ Beta-Eudesmol Product Offerings

7.3.5 AdooQ Recent Development

8 Industry Chain Analysis

8.1 Beta-Eudesmol Industrial Chain

8.2 Beta-Eudesmol Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Beta-Eudesmol Sales Model

8.5.2 Sales Channel

8.5.3 Beta-Eudesmol Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.1.1 Research Programs/Design

10.1.1.2 Market Size Estimation

10.1.1.3 Market Breakdown and Data Triangulation

10.1.2 Data Source

10.1.2.1 Secondary Sources

10.1.2.2 Primary Sources

10.2 Author Details

10.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Beta-Eudesmol Market Trends

Table 2. Beta-Eudesmol Market Drivers & Opportunity

Table 3. Beta-Eudesmol Market Challenges

Table 4. Beta-Eudesmol Market Restraints

Table 5. Global Beta-Eudesmol Revenue by Company (2020-2025) & (US$ Million)

Table 6. Global Beta-Eudesmol Revenue Market Share by Company (2020-2025)

Table 7. Global Beta-Eudesmol Sales Volume by Company (2020-2025) & (Kg)

Table 8. Global Beta-Eudesmol Sales Volume Market Share by Company (2020-2025)

Table 9. Global Market Beta-Eudesmol Price by Company (2020-2025) & (USD/Kg)

Table 10. Key Manufacturers Beta-Eudesmol Manufacturing Base and Headquarters

Table 11. Key Manufacturers Beta-Eudesmol Product Type

Table 12. Key Manufacturers Time to Begin Mass Production of Beta-Eudesmol

Table 13. Global Beta-Eudesmol Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Beta-Eudesmol as of 2024)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global Beta-Eudesmol Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)

Table 17. Global Beta-Eudesmol Sales Value by Type (2020-2025) & (US$ Million)

Table 18. Global Beta-Eudesmol Sales Value by Type (2026-2031) & (US$ Million)

Table 19. Global Beta-Eudesmol Sales Market Share in Value by Type (2020-2025)

Table 20. Global Beta-Eudesmol Sales Market Share in Value by Type (2026-2031)

Table 21. Global Beta-Eudesmol Sales Volume by Type: 2020 VS 2024 VS 2031 (Kg)

Table 22. Global Beta-Eudesmol Sales Volume by Type (2020-2025) & (Kg)

Table 23. Global Beta-Eudesmol Sales Volume by Type (2026-2031) & (Kg)

Table 24. Global Beta-Eudesmol Sales Market Share in Volume by Type (2020-2025)

Table 25. Global Beta-Eudesmol Sales Market Share in Volume by Type (2026-2031)

Table 26. Global Beta-Eudesmol Price by Type (2020-2025) & (USD/Kg)

Table 27. Global Beta-Eudesmol Price by Type (2026-2031) & (USD/Kg)

Table 28. Global Beta-Eudesmol Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)

Table 29. Global Beta-Eudesmol Sales Value by Application (2020-2025) & (US$ Million)

Table 30. Global Beta-Eudesmol Sales Value by Application (2026-2031) & (US$ Million)

Table 31. Global Beta-Eudesmol Sales Market Share in Value by Application (2020-2025)

Table 32. Global Beta-Eudesmol Sales Market Share in Value by Application (2026-2031)

Table 33. Global Beta-Eudesmol Sales Volume by Application: 2020 VS 2024 VS 2031 (Kg)

Table 34. Global Beta-Eudesmol Sales Volume by Application (2020-2025) & (Kg)

Table 35. Global Beta-Eudesmol Sales Volume by Application (2026-2031) & (Kg)

Table 36. Global Beta-Eudesmol Sales Market Share in Volume by Application (2020-2025)

Table 37. Global Beta-Eudesmol Sales Market Share in Volume by Application (2026-2031)

Table 38. Global Beta-Eudesmol Price by Application (2020-2025) & (USD/Kg)

Table 39. Global Beta-Eudesmol Price by Application (2026-2031) & (USD/Kg)

Table 40. Global Beta-Eudesmol Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)

Table 41. Global Beta-Eudesmol Sales Value by Region (2020-2025) & (US$ Million)

Table 42. Global Beta-Eudesmol Sales Value by Region (2026-2031) & (US$ Million)

Table 43. Global Beta-Eudesmol Sales Value by Region (2020-2025) & (%)

Table 44. Global Beta-Eudesmol Sales Value by Region (2026-2031) & (%)

Table 45. Global Beta-Eudesmol Sales Volume by Region (Kg): 2020 VS 2024 VS 2031

Table 46. Global Beta-Eudesmol Sales Volume by Region (2020-2025) & (Kg)

Table 47. Global Beta-Eudesmol Sales Volume by Region (2026-2031) & (Kg)

Table 48. Global Beta-Eudesmol Sales Volume by Region (2020-2025) & (%)

Table 49. Global Beta-Eudesmol Sales Volume by Region (2026-2031) & (%)

Table 50. Global Beta-Eudesmol Average Price by Region (2020-2025) & (USD/Kg)

Table 51. Global Beta-Eudesmol Average Price by Region (2026-2031) & (USD/Kg)

Table 52. Key Countries/Regions Beta-Eudesmol Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031

Table 53. Key Countries/Regions Beta-Eudesmol Sales Value, (2020-2025) & (US$ Million)

Table 54. Key Countries/Regions Beta-Eudesmol Sales Value, (2026-2031) & (US$ Million)

Table 55. Key Countries/Regions Beta-Eudesmol Sales Volume, (2020-2025) & (Kg)

Table 56. Key Countries/Regions Beta-Eudesmol Sales Volume, (2026-2031) & (Kg)

Table 57. Santa Cruz Biotechnology (SCBT) Company Information

Table 58. Santa Cruz Biotechnology (SCBT) Introduction and Business Overview

Table 59. Santa Cruz Biotechnology (SCBT) Beta-Eudesmol Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)

Table 60. Santa Cruz Biotechnology (SCBT) Beta-Eudesmol Product Offerings

Table 61. Santa Cruz Biotechnology (SCBT) Recent Development

Table 62. Merck KGaA (Sigma-Aldrich) Company Information

Table 63. Merck KGaA (Sigma-Aldrich) Introduction and Business Overview

Table 64. Merck KGaA (Sigma-Aldrich) Beta-Eudesmol Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)

Table 65. Merck KGaA (Sigma-Aldrich) Beta-Eudesmol Product Offerings

Table 66. Merck KGaA (Sigma-Aldrich) Recent Development

Table 67. AdooQ Company Information

Table 68. AdooQ Introduction and Business Overview

Table 69. AdooQ Beta-Eudesmol Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)

Table 70. AdooQ Beta-Eudesmol Product Offerings

Table 71. AdooQ Recent Development

Table 72. Key Raw Materials Lists

Table 73. Raw Materials Key Suppliers Lists

Table 74. Beta-Eudesmol Downstream Customers

Table 75. Beta-Eudesmol Distributors List

Table 76. Research Programs/Design for This Report

Table 77. Key Data Information from Secondary Sources

Table 78. Key Data Information from Primary Sources

List of Figures

Figure 1. Beta-Eudesmol Product Picture

Figure 2. Global Beta-Eudesmol Sales Value, 2020 VS 2024 VS 2031 (US$ Million)

Figure 3. Global Beta-Eudesmol Sales Value (2020-2031) & (US$ Million)

Figure 4. Global Beta-Eudesmol Sales Volume (2020-2031) & (Kg)

Figure 5. Global Beta-Eudesmol Sales Price (2020-2031) & (USD/Kg)

Figure 6. Beta-Eudesmol Report Years Considered

Figure 7. Global Beta-Eudesmol Players Revenue Ranking (2024) & (US$ Million)

Figure 8. Global Beta-Eudesmol Players Sales Volume Ranking (2024) & (Kg)

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Beta-Eudesmol Revenue in 2024

Figure 10. Beta-Eudesmol Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 11. Natural Type Picture

Figure 12. Synthetic Type Picture

Figure 13. Global Beta-Eudesmol Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)

Figure 14. Global Beta-Eudesmol Sales Value Market Share by Type, 2024 & 2031

Figure 15. Global Beta-Eudesmol Sales Volume by Type (2020 VS 2024 VS 2031) & (Kg)

Figure 16. Global Beta-Eudesmol Sales Volume Market Share by Type, 2024 & 2031

Figure 17. Global Beta-Eudesmol Price by Type (2020-2031) & (USD/Kg)

Figure 18. Product Picture of Essence

Figure 19. Product Picture of Sanitary Products

Figure 20. Product Picture of Industrial Products

Figure 21. Product Picture of Others

Figure 22. Global Beta-Eudesmol Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)

Figure 23. Global Beta-Eudesmol Sales Value Market Share by Application, 2024 & 2031

Figure 24. Global Beta-Eudesmol Sales Volume by Application (2020 VS 2024 VS 2031) & (Kg)

Figure 25. Global Beta-Eudesmol Sales Volume Market Share by Application, 2024 & 2031

Figure 26. Global Beta-Eudesmol Price by Application (2020-2031) & (USD/Kg)

Figure 27. North America Beta-Eudesmol Sales Value (2020-2031) & (US$ Million)

Figure 28. North America Beta-Eudesmol Sales Value by Country (%), 2024 VS 2031

Figure 29. Europe Beta-Eudesmol Sales Value, (2020-2031) & (US$ Million)

Figure 30. Europe Beta-Eudesmol Sales Value by Country (%), 2024 VS 2031

Figure 31. Asia Pacific Beta-Eudesmol Sales Value, (2020-2031) & (US$ Million)

Figure 32. Asia Pacific Beta-Eudesmol Sales Value by Region (%), 2024 VS 2031

Figure 33. South America Beta-Eudesmol Sales Value, (2020-2031) & (US$ Million)

Figure 34. South America Beta-Eudesmol Sales Value by Country (%), 2024 VS 2031

Figure 35. Middle East & Africa Beta-Eudesmol Sales Value, (2020-2031) & (US$ Million)

Figure 36. Middle East & Africa Beta-Eudesmol Sales Value by Country (%), 2024 VS 2031

Figure 37. Key Countries/Regions Beta-Eudesmol Sales Value (%), (2020-2031)

Figure 38. Key Countries/Regions Beta-Eudesmol Sales Volume (%), (2020-2031)

Figure 39. United States Beta-Eudesmol Sales Value, (2020-2031) & (US$ Million)

Figure 40. United States Beta-Eudesmol Sales Value by Type (%), 2024 VS 2031

Figure 41. United States Beta-Eudesmol Sales Value by Application (%), 2024 VS 2031

Figure 42. Europe Beta-Eudesmol Sales Value, (2020-2031) & (US$ Million)

Figure 43. Europe Beta-Eudesmol Sales Value by Type (%), 2024 VS 2031

Figure 44. Europe Beta-Eudesmol Sales Value by Application (%), 2024 VS 2031

Figure 45. China Beta-Eudesmol Sales Value, (2020-2031) & (US$ Million)

Figure 46. China Beta-Eudesmol Sales Value by Type (%), 2024 VS 2031

Figure 47. China Beta-Eudesmol Sales Value by Application (%), 2024 VS 2031

Figure 48. Japan Beta-Eudesmol Sales Value, (2020-2031) & (US$ Million)

Figure 49. Japan Beta-Eudesmol Sales Value by Type (%), 2024 VS 2031

Figure 50. Japan Beta-Eudesmol Sales Value by Application (%), 2024 VS 2031

Figure 51. South Korea Beta-Eudesmol Sales Value, (2020-2031) & (US$ Million)

Figure 52. South Korea Beta-Eudesmol Sales Value by Type (%), 2024 VS 2031

Figure 53. South Korea Beta-Eudesmol Sales Value by Application (%), 2024 VS 2031

Figure 54. Southeast Asia Beta-Eudesmol Sales Value, (2020-2031) & (US$ Million)

Figure 55. Southeast Asia Beta-Eudesmol Sales Value by Type (%), 2024 VS 2031

Figure 56. Southeast Asia Beta-Eudesmol Sales Value by Application (%), 2024 VS 2031

Figure 57. India Beta-Eudesmol Sales Value, (2020-2031) & (US$ Million)

Figure 58. India Beta-Eudesmol Sales Value by Type (%), 2024 VS 2031

Figure 59. India Beta-Eudesmol Sales Value by Application (%), 2024 VS 2031

Figure 60. Beta-Eudesmol Industrial Chain

Figure 61. Beta-Eudesmol Manufacturing Cost Structure

Figure 62. Channels of Distribution (Direct Sales, and Distribution)

Figure 63. Bottom-up and Top-down Approaches for This Report

Figure 64. Data Triangulation

Figure 65. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

Which companies rank high in the global Beta-Eudesmol market? zhanKai

The top companies in the global Beta-Eudesmol market are Santa Cruz Biotechnology (SCBT)、Merck KGaA (Sigma-Aldrich)、AdooQ.

Related Reports

Beta-Eudesmol- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Beta-Eudesmol was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-07-09
Pages: 124
USD 3950.00
(Single User License)
Global Beta-Eudesmol Market Research Report 2026
The global Beta-Eudesmol market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-04-25
Pages: 116
USD 2900.00
(Single User License)
Global Beta-Eudesmol Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Beta-Eudesmol market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-10-25
Pages: 114
USD 4900.00
(Single User License)
Global Beta-Eudesmol Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Beta-Eudesmol market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-21
Pages: 73
USD 4250.00
(Single User License)
Global Beta-Eudesmol Market Research Report 2025
The global market for Beta-Eudesmol was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-02-21
Pages: 81
USD 2900.00
(Single User License)
Global Beta-Eudesmol Market Insights, Forecast to 2030
Beta-Eudesmol, a sesquiterpenoid alcohol isolated from Atractylodes lancea rhizoma, potentiates the neuromuscular blocking effect of succinylcholine.
Published Date: 2024-04-07
Pages: 74
USD 4900.00
(Single User License)
Global Beta-Eudesmol Market Research Report 2024
Beta-Eudesmol, a sesquiterpenoid alcohol isolated from Atractylodes lancea rhizoma, potentiates the neuromuscular blocking effect of succinylcholine.
Published Date: 2024-02-05
Pages: 84
USD 2900.00
(Single User License)

Beta-Eudesmol- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Beta-Eudesmol was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-07-09
Pages: 124
USD 3950.00 (Single User License)
Global Beta-Eudesmol Market Research Report 2026
The global Beta-Eudesmol market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-04-25
Pages: 116
USD 2900.00 (Single User License)
Global Beta-Eudesmol Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Beta-Eudesmol market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-10-25
Pages: 114
USD 4900.00 (Single User License)
Global Beta-Eudesmol Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Beta-Eudesmol market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-21
Pages: 73
USD 4250.00 (Single User License)
Global Beta-Eudesmol Market Research Report 2025
The global market for Beta-Eudesmol was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-02-21
Pages: 81
USD 2900.00 (Single User License)
Global Beta-Eudesmol Market Insights, Forecast to 2030
Beta-Eudesmol, a sesquiterpenoid alcohol isolated from Atractylodes lancea rhizoma, potentiates the neuromuscular blocking effect of succinylcholine.
Published: 2024-04-07
Pages: 74
USD 4900.00 (Single User License)
Global Beta-Eudesmol Market Research Report 2024
Beta-Eudesmol, a sesquiterpenoid alcohol isolated from Atractylodes lancea rhizoma, potentiates the neuromuscular blocking effect of succinylcholine.
Published: 2024-02-05
Pages: 84
USD 2900.00 (Single User License)